Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "3"

News & Events

Term 3 school holiday workshops

The Kids Discovery Centre is offering a brand-new program of fun and engaging workshops for kids during the Term 3 School Holidays.

News & Events

ENVISAGE Term 3 programs

ENVISAGE is a free peer support program specifically designed for parents and caregivers of children aged 0-8 years with disabilities or developmental concerns. Term 3 dates now released.

News & Events

Term 3 school holiday workshops at Scitech

Everything you need to know to book tickets to our upcoming school holiday workshops held at Scitech!

News & Events

COVID-19 Update: Perth Lockdown 3 July 2021

ORIGINS is moving to virtual appointments and couriers to collect home samples during the June 2021 Perth lockdown.

Research

FeBRILe3– Fever, Blood cultures and Readiness for discharge in Infants Less than 3 months’ old

Tom Snelling BMBS DTMH GDipClinEpid PhD FRACP Head, Infectious Disease Implementation Research 08 6319 1817 tom.snelling@thekids.org.au Head,

Research

Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study

Disease caused by Streptococcus pneumoniae is associated with considerable morbidity and mortality in children. Pneumococcal conjugate vaccines are well tolerated and effective at reducing pneumococcal disease caused by vaccine serotypes. VAXNEUVANCE (V114) is a 15-valent PCV containing 13 serotypes in Prevnar 13, plus serotypes 22F and 33F. This large phase 3 study evaluated safety and tolerability of V114 in infants. 

Research

Predictors of hospital readmission in infants less than 3 months old

To examine rates and predictors of 7-day readmission in infants hospitalised before 3 months of age with infectious and non-infectious conditions. A retrospective population-based data-linkage study of 121 854 infants from a 5-year metropolitan birth cohort (2008-2012). Cox proportional hazard models were used to examine associations between infant and maternal factors with 7-day readmission.